Prognosia

What Prognosia does

Prognosia (prognosia.se) operates as a Swedish-language financial advisory blog publishing educational content on personal finance, pensions, savings, and investment topics. The site's content is organized into three categories — Pension, Sparande (Savings), and Aktier och fonder (Stocks and Funds) — and covers the Swedish pension system, fund selection, premiepension, AP-fonderna (AP funds), and consumer-oriented savings strategies. Articles have been published from at least 2019 through 2025 and are authored by a single admin contributor. The site provides a contact form and an [email protected] email address, and links to a Facebook group (facebook.com/groups/1970768703143593/) as its primary community channel. There is no disclosed pricing, advertising inventory, subscription model, app, or commercial product offering in the available source data, and the monetization model is not stated.

The input data contains material conflicts that materially affect any characterization of this entity. The firmographics block describes Prognosia as a for-profit financial services firm with 101-250 employees founded in 2007 in Göteborg providing wealth management, retirement planning, and investment consulting. A separate source describes "Prognosia Inc." as a US-incorporated medical imaging AI company that has licensed an AI-based breast cancer risk prediction technology from Washington University School of Medicine, with FDA Breakthrough Device designation granted in July 2025. Neither of these characterizations is corroborated by the first-party prognosia.se website, which is a Swedish personal-finance blog with a single author and content dating from 2019 onward. Per source-attribution rules, first-party company material is preferred for first-party facts; accordingly, this description is grounded primarily in the actual website content, with the conflict noted for the reader.

On the available evidence, Prognosia as represented by prognosia.se has no disclosed products, services, revenue model, partnerships, funding, or employees beyond a single admin author. Its sole observable "product" is an editorial content stream in Swedish covering consumer financial topics.

Name

Prognosia

Legal name

Prognosia.se

Website

https://prognosia.se

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

101–250 employees

Short description

Prognosia (prognosia.se) is a Swedish-language financial advisory blog publishing educational content on pensions, savings, stocks, and funds for Swedish retail readers, operated by a single admin author with no disclosed monetization model.

Ownership category

akta.pro rank

Product category

Personal Finance Content

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Retirement & Pension Planning (401(k)/IRA) (FSAEAAAD)

akta.pro secondary industry

Retirement Benefits & Social Security/Medicare Planning (FSAEABAI)

Keywords

• Pension planning advice
• Retirement savings education
• Personal finance blog
• Investment fund education
• Senior financial planning

Headquarters

HQ city

Göteborg

HQ country

Sweden

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Operations, Others

Core offering

Prognosia (Prognosia.se) operates a Swedish-language online financial advisory blog that publishes educational articles on pension planning, personal savings, retirement income, stock and fund investing, and senior finance topics. The website targets Swedish individual consumers and pensioners with localized content covering Swedish pension schemes such as Premiepension and AP-fonderna, alongside practical savings tips, loan guidance for pensioners, and investment education. No paid products, advisory fees, or transactional services are evidenced; the site functions as an editorial content resource.

Product overview

Prognosia Inc. offers a single AI-based medical imaging software product - an FDA Breakthrough Device-designated breast cancer risk assessment tool that analyzes mammogram images to predict five-year breast cancer risk. The software, licensed from WashU Medicine, represents the company's sole product offering focused on early cancer detection and risk assessment through advanced image analysis.

Differentiator

Problem solved

Functional benefit

Products and services

• Prognosia.se Financial Advisory Blog Swedish-language online financial advisory blog publishing educational articles on pension planning, personal savings, retirement income, stock and fund investing, and senior finance topics for Swedish consumers and pensioners.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature1 record

Partnerships

One partnership is on record.

• Washington University School of Medicine (WashU Medicine)coreTechnology or Integration · 29 July 2025Prognosia Inc. licensed an AI-based technology developed at WashU Medicine for analyzing mammograms to predict breast cancer risk. The technology received FDA Breakthrough Device designation in July 2025. This is a technology in-licensing arrangement where Prognosia gained commercial rights to the AI technology developed by the university.

Recent moves2 records

Expansion highlights1 record

Emerging players

• Tink (Visa): Stockholm-based open banking/data platform that powers Swedish financial comparison and personal finance management experiences; adjacent because it enables the same kind of consumer Swedish financial content and comparison products.

Direct peers

• Nordnet Bank: Major Swedish retail investment and pension platform that publishes extensive educational content on pensions, savings, and fund selection; comparable to Prognosia because it monetises Swedish retail retirement attention through content-plus-product.
• Avanza: Sweden's largest retail pension and investment platform with a large media/personal finance content arm covering privatekonomi and PPM choices; directly comparable target audience and Swedish-language financial content distribution model.
• Compricer (Lendo Group): Swedish comparison site for private loans, mortgages and personal finance; comparable because it monetises content on Swedish household financial decisions adjacent to pension and savings topics.
• Lysa: Swedish robo-advisor focused on long-term savings and pensions with educational content aimed at retail investors; comparable in addressing the same Swedish retail retirement-planning audience that Prognosia targets with its blog.

Broad incumbents

• Skandia: Large Swedish life and pensions company with consumer-facing retirement-planning resources; comparable as a broader incumbent in the same Swedish pension advisory space where Prognosia's content competes for consumer attention.
• Handelsbanken Liv: Major Swedish bank's pension and savings division with extensive privatekonomi and pension educational content; comparable as an incumbent financial institution publishing retirement-targeted content to Swedish retail customers.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights4 records

Customer concentration

• Facebookfacebook.com/groups/1970768703143593
• Xx.com/Prognosia

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prognosia